COVID-19
The US government is canceling around $500 million worth of vaccine development projects using mRNA technology, a decision that has triggered criticism from public health experts and officials. The 22 terminated projects, funded through the Biomedical Advanced Research and Development Authority (Barda), included vaccine efforts for Covid-19, flu, and bird
COVID-19
GSK will receive a significant payment as a result of the resolution of patent litigation between CureVac and BioNTech in the United States. The biopharmaceutical company will receive USD370m upfront, with a portion tied to an amendment reducing royalties GSK owes on potential future mRNA vaccines. Additionally, GSK will collect
COVID-19
CureVac NV has withdrawn its agreement to settle a patent dispute with Pfizer/BioNTech, involving COVID-19 vaccine technology, with CureVac claiming infringement by Pfizer/BioNTech's Comirnaty vaccine. The withdrawal means the dispute will proceed to trial, potentially leading to a lengthy and costly process. This decision comes after
COVID-19
The move by HHS Secretary Robert F. Kennedy Jr. to cut funding for mRNA vaccine development has sparked widespread concern among experts and manufacturers, who argue that the technology has proven effective against COVID-19 and holds promise for treating other diseases. Despite the decision, mRNA vaccines continue to show promise,
COVID-19
The European AIDS Treatment Group has expressed concern over the decision by the Health and Human Services (HHS) to cancel almost $500 million dollars in funding for the development of messenger RNA (mRNA) vaccines. Despite the proven safety and effectiveness of mRNA vaccines, which have been credited with saving tens
COVID-19
The US Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. announced the federal government's decision to cancel half a billion dollars' worth of investments in mRNA Covid-19 vaccine technology, citing a desire to move beyond the "limitations" of mRNA vaccines. This decision has
COVID-19
A fatal shooting at Emory University's downtown Atlanta campus left a DeKalb County officer dead and the suspected shooter dead. The incident occurred around 4:50 p.m. EDT at the Emory Point CVS, a shopping center that houses a CVS, restaurants, shops, and apartments where some students
COVID-19
Taipei's Centers for Disease Control and Prevention has established Special Pathogen Treatment Centers at three hospitals to manage new infections that could pose public health risks. The new facilities aim to enhance Taiwan's disease control response and rapid treatment of suspected cases from abroad. According to
COVID-19
CureVac, a multinational biotech company, has resolved all pending patent litigation in the US related to mRNA-based COVID-19 vaccines with Pfizer and BioNTech. This resolution removes a significant overhang for CureVac, allowing the company to focus on its vaccine and treatment candidates. The agreement also includes a payment of $740
COVID-19
British pharmaceutical giant GSK PLC has reached a patent settlement with CureVac BV over mRNA vaccine technology, involving US-based BioNTech SE and Pfizer Inc. As part of the agreement, GSK is set to receive an upfront payment of USD370 million from CureVac. This payment will be made in two parts:
COVID-19
In Alberta, Canada, a severe measles outbreak has occurred, with over 1,600 cases reported, mostly in culturally conservative Mennonite communities with low vaccination rates. The outbreak has eroded the protection provided by a high vaccination rate in the general population, with the percentage of 7-year-olds fully vaccinated against measles
COVID-19
Dr. Katalin Karikó, the Nobel Prize-winning scientist behind mRNA vaccine technology, has strongly criticized the US health secretary's plan to effectively cancel the use and development of the science in America. Speaking to The Telegraph, Dr. Karikó described the decision as "devastating" and a "lack
